Sunday 4 February 2024
With today being #WorldCancerDay we thought it’s the perfect opportunity to announce this year’s ANZCHOG Annual Scientific Meeting!
This year’s ASM will run from 1 – 3 August and submissions for abstracts are now open. It’s all happening in Adelaide (Tarntanya) this year, with the theme, “Sparking hope through cutting edge technologies and collaborative care. Tangka parranthi.”. Tangka parranthi means “sparking hope” in the native language of the Kaurna people, the traditional owners of the Adelaide Plains of South Australia.
The three-year theme of World Cancer Day is to #CloseTheCareGap and ANZCHOG’s ASM aims to achieve this by uniting diverse experts to drive innovation, foster collaboration and enhance care. The ASM provides the opportunity to share collective experiences, learn about new therapies, and network with national and international colleagues in order to drive improvements in paediatric oncology and haematology. This collaborative approach helps close the care cap for children in Australia, New Zealand and even globally.
We are currently inviting those interested to submit an abstract for either poster or oral presentations under the following themes:
- Allied health
- Indigenous health
- Leukaemia/ Lymphoma
- Neuro oncology
- Non-malignant haematology
- Patient experience
- Precision medicine and targeted therapies
- Quality care improvements
- Solid tumors
- Supportive/ palliative care
- Survivorship and transition
- Transplant and cellular therapy
For more information on the ANZCHOG ASM, or submitting an abstract, please visit the ANZCHOG ASM website.
ANZCHOG is a non-profit organisation committed to ensuring Australian and New Zealand children receive world-class cancer care. We are the peak professional body for paediatric oncologists and health professionals who care for children with cancer, spearheading national initiatives to enhance clinical care through communication, research, networking and education. We are also the national cooperative clinical trials group for childhood cancer, actively working with trial consortia around the globe to ensure Australian and New Zealand children have the opportunity to access the latest promising cancer treatments.